Loading...
XHKG
3839
Market cap230mUSD
Dec 05, Last price  
7.44HKD
1D
-1.98%
1Q
18.85%
Jan 2017
235.14%
IPO
89.31%
Name

Chia Tai Enterprises International Ltd

Chart & Performance

D1W1MN
XHKG:3839 chart
P/E
20.60
P/S
0.75
EPS
0.05
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
23.98%
Revenues
308m
+76.89%
132,274,000122,219,000117,131,000101,767,00087,276,00074,466,00093,362,000105,042,00093,577,000142,407,000159,239,000173,979,000307,748,000
Net income
11m
+337.45%
17,714,00027,790,00019,430,0008,182,0008,058,00016,347,00021,164,00015,800,00016,255,00026,696,000-4,259,0002,553,00011,168,000
CFO
11m
P
15,747,000-3,687,00016,882,0009,870,00019,303,000-1,593,00016,571,000-7,340,0004,034,000-10,911,0005,629,000-16,062,00011,285,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment manufactures and sells CTC premix and CTC hydrochloride products, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands. The Industrial segment engages in the sale, leasing, and servicing of caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as spare parts; and manufacture and sale of carburetors and automotive parts for automobile and motorcycle manufacturers. The company was incorporated in 1987 and is based in Central, Hong Kong. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited.
IPO date
Jul 03, 2015
Employees
1,000
Domiciled in
HK
Incorporated in
BM

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT